Abstract
Dranove JE, Horn DS, Davis MA, Kernek KM, Gupta SK. J Pediatr . 2009;154(1):96–100 PURPOSE OF THE STUDY. To determine predictors of the histologic response to proton pump inhibitor (PPI) therapy among children with significant esophageal eosinophilia (SEE), defined as ≥15 eosinophils per high-powered field (hpf) on esophageal mucosal biopsy (EMB). STUDY POPULATION. Patients between the ages of 1 and 18 years who underwent esophagogastroduodenoscopy between 1999 and 2006 were eligible for the study. Indications for esophagogastroduodenoscopy included regurgitation, vomiting, heartburn, abdominal pain, dysphagia, …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
